Zevra Therapeutics Inc (ZVRA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2024 | 09-2024 | 06-2024 | 03-2024 | 12-2023 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -105,511 | -69,772 | -36,547 | -16,622 | -46,049 |
| Depreciation Amortization | 5,499 | 4,741 | 3,124 | 1,562 | 1,006 |
| Accounts receivable | 6,868 | 9,587 | 8,430 | 9,072 | -9,078 |
| Other Working Capital | 14,480 | 3,417 | 1,631 | -148 | 5,883 |
| Other Operating Activity | 8,999 | -1,388 | -11,912 | -10,029 | 14,703 |
| Operating Cash Flow | $-69,665 | $-53,415 | $-35,274 | $-16,165 | $-33,535 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | N/A | N/A | N/A | N/A | -296 |
| Net Acquisitions | N/A | N/A | N/A | N/A | -30,401 |
| Purchase Of Investment | -41,161 | -41,488 | -129 | N/A | -45,814 |
| Sale Of Investment | 25,000 | 24,798 | 14,793 | 14,793 | 59,121 |
| Other Investing Activity | -6,000 | 0 | 0 | 0 | 0 |
| Investing Cash Flow | $-22,161 | $-16,690 | $14,664 | $14,793 | $-17,390 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 60,072 | 60,072 | 60,072 | N/A | 43,687 |
| Debt Repayment | -43,131 | -43,131 | -43,131 | N/A | -18,100 |
| Common Stock Issued | 67,258 | 66,462 | 1,697 | 1,217 | 6,324 |
| Common Stock Repurchased | N/A | N/A | N/A | N/A | -3,447 |
| Other Financing Activity | -2,091 | -2,091 | -2,091 | 0 | 0 |
| Financing Cash Flow | $82,108 | $81,312 | $16,547 | $1,217 | $28,464 |
| Exchange Rate Effect | 454 | -217 | 274 | -45 | 44 |
| Beginning Cash Position | 43,049 | 43,049 | 43,049 | 43,049 | 65,466 |
| End Cash Position | 33,785 | 54,039 | 39,260 | 42,849 | 43,049 |
| Net Cash Flow | $-9,264 | $10,990 | $-3,789 | $-200 | $-22,417 |
| Free Cash Flow | |||||
| Operating Cash Flow | -69,665 | -53,415 | -35,274 | -16,165 | -33,535 |
| Capital Expenditure | N/A | 0 | 0 | N/A | -296 |
| Free Cash Flow | -69,665 | -53,415 | -35,274 | -16,165 | -33,831 |